IPERION LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.003 NZD | 0.00% |
|
0.00% | 0.00% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 3.09M 5.19M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
| Net cash position 2022 | 2M 3.36M | Net cash position 2023 | 1.59M 2.68M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-25.1
x | P/E ratio 2023 |
-11
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 2.89% |
More Fundamentals
* Assessed data
More news
| 6 months | -50.00% |
1 month
0.00
0.00
Current year
0.000.00
1 year
0.000.01
3 years
0.000.01
5 years
0.000.01
10 years
0.000.02
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 13-12-08 | |
| Director of Finance/CFO | - | - | |
Peter Binny
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | - | |
Ku Ee Chang
CHM | Chairman | - | 18-12-16 |
Ng Kuan Chong
BRD | Director/Board Member | - | 19-04-07 |
Iperion Limited, formerly Southern Charter Financial Group Limited, is a New Zealand-based company. The Company is in the process of setting up facilities for the production and commercialization of antimicrobial compounds.
Sector
IT Services & Consulting
Calendar
2024-05-26
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 917K | |
| -11.94% | 194B | |
| +0.74% | 167B | |
| +3.28% | 155B | |
| +5.74% | 101B | |
| +6.13% | 76.69B | |
| +16.72% | 72.08B | |
| -7.30% | 71.48B | |
| -23.37% | 50.93B | |
| +0.53% | 48.89B |
- Stock Market
- Equities
- IPR Stock
